Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPTC Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 3 | -$1.67 | -$0.84 | -$1.23 |
| Q2 2025 | 2 | -$2.45 | -$0.19 | -$0.99 |
| Q3 2025 | 2 | -$1.61 | -$0.12 | -$0.65 |
| Q4 2025 | 2 | -$1.70 | -$0.13 | -$0.69 |
| Q1 2026 | 1 | -$0.84 | -$0.06 | -$0.34 |
| Q2 2026 | 1 | -$0.30 | -$0.02 | -$0.12 |
| Q3 2026 | 1 | $0.01 | $0.17 | $0.07 |
| Q4 2026 | 1 | $0.03 | $0.42 | $0.17 |
| Q1 2027 | 1 | $0.11 | $1.47 | $0.60 |
| Q2 2027 | 1 | $0.13 | $1.69 | $0.68 |
| Q3 2027 | 1 | $0.12 | $1.62 | $0.66 |
| Q4 2027 | 1 | $0.53 | $6.97 | $2.83 |
PTC Therapeutics, Inc. Earnings Date And Information
PTC Therapeutics, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-1.39 earnings per share for the quarter, topping analysts' consensus estimates of $-1.54 by $0.15. The company had revenue of 196.79 M for the quarter and had revenue of 937.82 M for the year. PTC Therapeutics, Inc. has generated $-8 earnings per share over the last year ($-8.37 diluted earnings per share) and currently has a price-to-earnings ratio of -7.1. PTC Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
PTC Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$1.54 | -$1.39 | 0.15 | $170.59 M | $196.79 M |
| 08/08/2024 | Q2 2024 | -$1.00 | -$1.29 | -0.29 | $183.28 M | $186.70 M |
| 04/25/2024 | Q1 2024 | -$1.21 | -$1.20 | 0.01 | $210.12 M | |
| 02/29/2024 | Q4 2023 | $0.29 | -$2.06 | -2.35 | $307.06 M | |
| 10/26/2023 | Q3 2023 | -$0.85 | -$1.76 | -0.91 | $210.23 M | $196.58 M |
| 08/03/2023 | Q2 2023 | -$1.58 | -$2.66 | -1.08 | $206.99 M | $213.81 M |
| 04/27/2023 | Q1 2023 | -$1.64 | -$1.88 | -0.24 | $220.38 M | |
| 02/21/2023 | Q4 2022 | -$1.96 | -$2.35 | -0.39 | $167.41 M | |
| 10/27/2022 | Q3 2022 | -$1.37 | -$1.53 | -0.16 | $178.52 M | $217.13 M |
| 08/04/2022 | Q2 2022 | -$1.67 | -$2.13 | -0.46 | $162.12 M | $165.53 M |
| 05/03/2022 | Q1 2022 | -$1.55 | -$1.78 | -0.23 | $148.74 M | |
| 02/22/2022 | Q4 2021 | -$1.79 | -$2.03 | -0.24 | $165.23 M | |
| 10/28/2021 | Q3 2021 | -$1.78 | -$1.89 | -0.11 | $120.44 M | $138.74 M |
| 07/29/2021 | Q2 2021 | -$1.84 | -$1.68 | 0.16 | $110.13 M | $116.68 M |
| 05/04/2021 | Q1 2021 | -$1.59 | -$1.83 | -0.24 | $117.94 M | |
| 02/25/2021 | Q4 2020 | -$0.90 | -$1.08 | -0.18 | $118.86 M | |
| 10/29/2020 | Q3 2020 | -$1.10 | -$1.03 | 0.07 | $112.21 M | $118.40 M |
| 08/05/2020 | Q2 2020 | -$1.29 | -$2.78 | -1.49 | $82.04 M | $75.24 M |
| 04/30/2020 | Q1 2020 | -$1.16 | -$1.81 | -0.65 | $68.26 M | |
| 03/02/2020 | Q4 2019 | -$0.53 | -$1.25 | -0.72 | $96.46 M |
PTC Therapeutics, Inc. Earnings: FAQ's
When is PTC Therapeutics, Inc.'s earnings date?
PTC Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
Did PTC Therapeutics, Inc. beat their earnings estimates last
quarter?
In the previous quarter, PTC Therapeutics, Inc. (:PTCT) reported $-1.39 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.54 by $0.15.
How can I listen to PTC Therapeutics, Inc.'s earnings conference
call?
The conference call for PTC Therapeutics, Inc.'s latest earnings report can be listened to online.
How can I read PTC Therapeutics, Inc.'s conference call transcript?
The conference call transcript for PTC Therapeutics, Inc.'s latest earnings report can be read online.
How much revenue does PTC Therapeutics, Inc. generate each year?
PTC Therapeutics, Inc. (:PTCT) has a recorded annual revenue of $937.82 M.
How much profit does PTC Therapeutics, Inc. generate each year?
PTC Therapeutics, Inc. (:PTCT) has a recorded net income of $937.82 M. PTC Therapeutics, Inc. has generated $-8.37 earnings per share over the last four quarters.
What is PTC Therapeutics, Inc.'s price-to-earnings ratio?
PTC Therapeutics, Inc. (:PTCT) has a price-to-earnings ratio of -7.1 and price/earnings-to-growth ratio is -1.21.